Evidence map›Paper›PMID 27884146›Full record

ArticleMalaria journal2016

Demographic and clinical profiles of Plasmodium falciparum and Plasmodium vivax patients at a tertiary care centre in southwestern India.

Laura Chery, Jennifer N Maki, Anjali Mascarenhas, Jayashri T Walke, Pooja Gawas, Anvily Almeida, Mezia Fernandes, Marina Vaz, Rakesh Ramanan, Diksha Shirodkar and 30 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Magnitude and patterns of severeFrontiers in medicine · 2023
    Article
  7. Targeting plasmodium α-tubulin-1 to block malaria transmission to mosquitoes.Frontiers in cellular and infection microbiology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Evaluating Generalizability of a Biospecimen Informatics Approach: Support for Local Requirements and Best Practices.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2018
    Article
  17. Article
  18. Article
  19. Clinical spectrum ofTropical parasitology
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 6 institutions in 2 countries.

Laura CheryDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Jennifer N MakiDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Anjali MascarenhasDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Jayashri T WalkeDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Pooja GawasDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Anvily AlmeidaDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Mezia FernandesDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Marina VazGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Rakesh RamananGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Diksha ShirodkarGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Maria BernabeuCenter for Infectious Disease Research (CIDR), Seattle, WA, 98109, USA.
Suresh Kumar ManoharanDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Ligia PereiraDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Rashmi DashDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Ambika SharmaDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Riaz Basha ShaikDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Rimi ChakrabartiDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Prasad BabarDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
John WhiteDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Devaraja G MudeppaDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Shiva KumarDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
Wenyun ZuoDepartment of Biology, Stanford University, Stanford, CA, 94305, USA.
Kristen M SkillmanDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
Usheer KanjeeDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
Caeul LimDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
Kathryn Shaw-SalibaDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
Ashwani KumarNational Institute of Malaria Research, Field Unit, Campal, Goa, 403001, India.
Neena ValechaNational Institute of Malaria Research (ICMR), Sector 8, Dwarka, New Delhi, 110077, India.
V N JindalGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Anar KhandeparkarGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Pradeep NaikGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Sunanda AmonkarGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Manoj T DuraisinghDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
Shripad TuljapurkarDepartment of Biology, Stanford University, Stanford, CA, 94305, USA.
Joseph D SmithCenter for Infectious Disease Research (CIDR), Seattle, WA, 98109, USA.
Nagesh DubhashiGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Roque G W PintoGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Maria SilveriaGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Edwin GomesGoa Medical College and Hospital, Bambolim, Goa, 403202, India.
Pradipsinh K RathodDepartments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA. rathod@chem.washington.edu.ORCID 0000-0001-7394-1360
University of Washington · USGoa Medical College · INHarvard University · USCenter for Infectious Disease Research · USNational Institute of Malaria Research · INStanford University · US

Funding

Shared TechnologyU19AI089688 · NIAID · UNIVERSITY OF WASHINGTON · PI RATHOD, PRADIPSINH K. · 2010 to 2023
$22.4M
NIAID NIH HHS U19 AI089688
6 · The paper itself

Abstract

backgroundMalaria remains an important cause of morbidity and mortality in India. Though many comprehensive studies have been carried out in Africa and Southeast Asia to characterize and examine determinants of Plasmodium falciparum and Plasmodium vivax malaria pathogenesis, fewer have been conducted in India.

methodsA prospective study of malaria-positive individuals was conducted at Goa Medical College and Hospital (GMC) from 2012 to 2015 to identify demographic, diagnostic and clinical indicators associated with P. falciparum and P. vivax infection on univariate analysis.

resultsBetween 2012 and 2015, 74,571 febrile individuals, 6287 (8.4%) of whom were malaria positive, presented to GMC. The total number of malaria cases at GMC increased more than two-fold over four years, with both P. vivax and P. falciparum cases present year-round. Some 1116 malaria-positive individuals (mean age = 27, 91% male), 88.2% of whom were born outside of Goa and 51% of whom were construction workers, were enroled in the study. Of 1088 confirmed malaria-positive patients, 77.0% had P. vivax, 21.0% had P. falciparum and 2.0% had mixed malaria. Patients over 40 years of age and with P. falciparum infection were significantly (p < 0.001) more likely to be hospitalised than younger and P. vivax patients, respectively. While approximately equal percentages of hospitalised P. falciparum (76.6%) and P. vivax (78.9%) cases presented with at least one WHO severity indicator, a greater percentage of P. falciparum inpatients presented with at least two (43.9%, p < 0.05) and at least three (29.9%, p < 0.01) severity features. There were six deaths among the 182 hospitalised malaria positive patients, all of whom had P. falciparum.

conclusionDuring the four year study period at GMC, the number of malaria cases increased substantially and the greatest burden of severe disease was contributed by P. falciparum.

Indexed as

AdolescentAdultAgedChildChild, PreschoolDemographyFemaleHumansIncidenceIndiaInfantMalaria, FalciparumMalaria, VivaxMaleMiddle AgedProspective StudiesCharacteristicsDiagnosticsEpidemiologyFeaturesGoaMESA-ICEMRSeverity

Identifiers

PMID27884146
PMCPMC5123287
OpenAlexW2551569108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.